Effect of isotretinoin treatment on inflammatory and hematological parameters in patients with acne vulgaris

References

• Kraft J, Freiman A. Management of acne. CMAJ. 2011;183(7):e430–e435. doi: 10.1503/cmaj.090374.
   PubMed Web of Science ®Google Scholar
• Karadag AS, Ertugrul DT, Bilgili SO, et. al. Immunoregulatory effects of isotretinoin in patients with acne. Br J Dermatol. 2012;167(2):433–435. doi: 10.1111/j.1365-2133.2012.10949.x.
   PubMed Web of Science ®Google Scholar
• Vallerand IA, Lewinson RT, Farris MS, et al. Efficacy and adverse events of oral isotretinoin for acne: a systematic review. Br J Dermatol. 2018;178(1):76–85. doi: 10.1111/bjd.16195.
   PubMed Web of Science ®Google Scholar
• Kutlu Ö. Ö. Effect of isotretinoin treatment on the inflammatory markers in patients with acne vulgaris: can monocyte/HDL be a new indicator for inflammatory activity of isotretinoin treatment? Cutan Ocul Toxicol. 2020;39(1):67–70. doi: 10.1080/15569527.2019.1701485.
   PubMed Web of Science ®Google Scholar
• Önder S, Ozturk M. Can monocyte/HDL show inflammatory activity of isotretinoin treatment in acne patients? Cutan Ocul Toxicol. 2020;39(2):111–114. doi: 10.1080/15569527.2020.1734815.
   PubMed Web of Science ®Google Scholar
• Metin N, Turan Ç. Ç. Increases in uric acid and monocyte-high-density lipoprotein ratio as possible atherosclerotic indicators in acne patients using isotretinoin. J Cosmet Dermatol. 2021;20(9):2945–2949. doi: 10.1111/jocd.13931.
   PubMed Web of Science ®Google Scholar
• Hareedy MS, Tawfik KM. Systemic isotretinoin has an impact on hemoglobin, ferritin, urea, ceruloplasmin, albumin, uric acid levels, and neutrophil to lymphocyte ratio in acne patients. J Cosmet Dermatol. 2022;21(11):6191–6198. doi: 10.1111/jocd.15199.
   PubMed Web of Science ®Google Scholar
• Imtiaz F, Shafique K, Mirza SS, et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in asian population. Int Arch Med. 2012;5(1):2. doi: 10.1186/1755-7682-5-2.
   PubMedGoogle Scholar
• Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol. 2006;80(5):1156–1164. doi: 10.1189/jlb.0206125.
   PubMed Web of Science ®Google Scholar
• Kannel WB, Wilson PW. Efficacy of lipid profiles in prediction of coronary disease. Am Heart J. 1992;124(3):768–774. doi: 10.1016/0002-8703(92)90288-7.
   PubMed Web of Science ®Google Scholar
• Saklamaz A, Uyar B, Yalcin M, et al. Isotretinoin increased carotid intima-media thickness in acne patients. Hippokratia. 2016;20(1):14–18.
   PubMed Web of Science ®Google Scholar
• Cosansu NC, Yuksekal G, Turan U, et al. Investigation of systemic immune-inflammation index and systemic inflammation response index as an indicator of the anti-inflammatuary effect of isotretinoin in patients with acne vulgaris. Cutan Ocul Toxicol. 2022;41(2):174–178. doi: 10.1080/15569527.2022.2081700.
   PubMed Web of Science ®Google Scholar
• von Bibra H, Ströhle A, St John Sutton M, et al. Dietary therapy in heart failure with preserved ejection fraction and/or left ventricular diastolic dysfunction in patients with metabolic syndrome. Int J Cardiol. 2017;234:7–15. doi: 10.1016/j.ijcard.2017.01.003.
   PubMed Web of Science ®Google Scholar
• Jeppesen J. Triglycerides, high-density lipoprotein cholesterol, and risk of ischemic heart disease: a view from the Copenhagen male study. Metab Syndr Relat Disord. 2003;1(1):33–53. doi: 10.1089/154041903321648243.
   PubMed Web of Science ®Google Scholar
• Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the helsinki heart study. Impl Treat Circulat. 1992;85(1):37–45. doi: 10.1161/01.CIR.85.1.37.
   PubMed Web of Science ®Google Scholar
• Packard CJ, Ford I, Robertson M, et al. Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation. 2005;112(20):3058–3065. doi: 10.1161/CIRCULATIONAHA.104.526848.
   PubMed Web of Science ®Google Scholar
• Yurtdaş M, Yaylali YT, Kaya Y, et al. Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis. Echocardiography. 2014;31(9):1095–1104. doi: 10.1111/echo.12511.
   PubMed Web of Science ®Google Scholar
• Temiz A, Gazi E, Güngör Ö, et al. Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit. 2014;20:660–665. doi: 10.12659/MSM.890152.
   PubMed Web of Science ®Google Scholar
• Litman GW, Cannon JP, Dishaw LJ. Reconstructing immune phylogeny: new perspectives. Nat Rev Immunol. 2005;5(11):866–879. doi: 10.1038/nri1712.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhang J, Zhong Y, et al. Predictive value of the monocyte-to-lymphocyte ratio in the diagnosis of prostate cancer. Medicine. 2021;100(38):e27244. doi: 10.1097/MD.0000000000027244.
   PubMed Web of Science ®Google Scholar
• Song W, Wang K, Zhang RJ, et al. Prognostic value of the lymphocyte monocyte ratio in patients with colorectal cancer: a meta-analysis. Medicine. 2016;95(49):e5540. doi: 10.1097/MD.0000000000005540.
   PubMed Web of Science ®Google Scholar
• Nishijima TF, Muss HB, Shachar SS, et al. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015;41(10):971–978. doi: 10.1016/j.ctrv.2015.10.003.
   PubMed Web of Science ®Google Scholar
• Song Y, Zhao Y, Shu Y, et al. Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: a cross-sectional study. Front Endocrinol. 2023;14:1100453. doi: 10.3389/fendo.2023.1100453.
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Chin-Dusting JPF, Sviridov D, et al. The anti inflammatory effects of high density lipoproteins. Curr Med Chem. 2009;16(6):667–675. doi: 10.2174/092986709787458425.
   PubMed Web of Science ®Google Scholar
• Çetinarslan T, Türel Ermertcan A, Özyurt B, et al. Evaluation of the laboratory parameters in hidradenitis suppurativa: Can we use new inflammatory biomarkers? Dermatol Ther. 2021;34(2):e14835.
   PubMed Web of Science ®Google Scholar
• Ganjali S, Gotto AM, Ruscica M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12):9237–9246. doi: 10.1002/jcp.27028.
   PubMed Web of Science ®Google Scholar
• Chen H, Xiong C, Shao X, et al. Lymphocyte to high-density lipoprotein ratio as a new indicator of inflammation and metabolic syndrome. Diabetes Metab Syndr Obes. 2019;12:2117–2123. doi: 10.2147/DMSO.S219363.
   PubMed Web of Science ®Google Scholar
• Lamichhane P, Agrawal A, Abouainain Y, et al. Utility of neutrophil-to-high-density lipoprotein-cholesterol ratio in patients with coronary artery disease: a narrative review. J Int Med Res. 2023;51(4):3000605231166518. doi: 10.1177/03000605231166518.
   Web of Science ®Google Scholar
• Jialal I, Jialal G. Adams-Huet B. The platelet to high density lipoprotein -cholesterol ratio is a valid biomarker of nascent metabolic syndrome. Diabetes Metab Res Rev. 2021;37(6):e3403.
   PubMed Web of Science ®Google Scholar
• Yu S, Guo X, Li G, et al. Lymphocyte to High-Density lipoprotein ratio but not platelet to lymphocyte ratio effectively predicts metabolic syndrome among subjects from rural China. Front Cardiovasc Med. 2021;8:583320. doi: 10.3389/fcvm.2021.583320.
   PubMed Web of Science ®Google Scholar